// App-Quantinova.ai

3310 : Riboflavin targets autofluorescent-positive breast cancer stem cells upon light exposure

Researchers

Presenter

  • Shamileh Fouladdel

Principal Investigators

  • Tahra Luther

  • Kaitlin Harvey

  • Rachel Martin-Trevino

  • Jill Granger

  • Ebrahim Azizi

  • Max S. Wicha

Medical Centers

  • University of Michigan, Ann Arbor, MI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • ATP-binding cassette super-family G member 2

  • Breast cancer type 1 susceptibility protein

  • Cluster of Differentiation 24

  • Cluster of Differentiation 44

  • Proliferating cell nuclear antigen

  • Proliferation marker protein Ki-67

  • Enhancer of zeste homolog 2

Drug/Treatment

  • Ribo-100

  • EZH2

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved